Masahiko MoriyamaPresident & Representative Director This is Moriyama from T&D Holdings. Thank you very much for taking the time out of your busy schedules...
This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As...
When it comes to house flipping, the buyer should always beware. A house-flipping reality-show host and a life coach who has hawked self-help programs...
The moments between your milestones are not filler.”― Nelou Keramati. Today, we put Milestone Pharmaceuticals Inc. (NASDAQ:MIST) in the spotlight for the first time....
Ginkgo Bioworks’ (NYSE:DNA) first quarter results were something of a mixed bag, with continued progression on a number of metrics offset by rising costs...
Hello and welcome to Financial Face-off, a MarketWatch column where we help you weigh a financial decision. Our columnist will give her verdict. Tell...
Although the recent sell-off in AT&T (NYSE:T) may have been unjustified, a long-term analysis of their continuing operations reveals a company that has done...